Dr. Nik Gravenstein Joins Xhale Assurance, Inc. as Chief Medical Advisor GAINESVILLE, FL October 19, 2017 Xhale Assurance, Inc., a medical technology company developing and commercializing unique monitoring solutions for the pharmaceutical and healthcare industries, announced today the appointment of Dr. Nik Gravenstein to the role of Chief Medical Advisor. For Dr. Nikolaus Gravenstein, upholding […]
GAINESVILLE, FL August 31, 2017 – Xhale Assurance, Inc. Xhale Assurance, Inc. announced it has received FDA approval for its Nasal Alar Sp02 Sensor for use on patients at least 4 years old and weighing at least 15kg who are well or poorly perfused. This is in response to clinician demand at children’s hospitals for […]
Xhale Assurance and its exclusive distribution partner Tri-anim announced today that they will showcase Xhale Assurance’s Nasal Alar SpO2 Sensor at the American Association for Respiratory Care (AARC) 2017 Annual Meeting. The meeting will be taking place October 4-7, 2017 at the Indiana Convention Center in Indianapolis, IN.
Xhale Assurance and its exclusive distribution partner Tri-anim announced today that they will showcase Xhale Assurance’s Nasal Alar SpO2 Sensor at the American Society of Anesthesiologists (ASA) 2017 Annual Meeting. The meeting will be taking place October 21-25, 2017 at the Boston Convention and Exhibition Center in Boston, MA.
Xhale Assurance announced today that it will showcase its Nasal Alar SpO2 Sensor at the 2018 National Teaching Institute & Critical Care Exposition presented by the American Association of Critical Care Nurses. The Institute & Exposition will be taking place May 22-24, 2018 at the Boston Convention & Exhibits Center in Boston, MA.
Xhale Assurance announced today that it will showcase its Nasal Alar SpO2 Sensor at the Society of Critical Care Medicine’s (SCCM) 47th Critical Care Congress. The Congress will be taking place February 25 – 28, 2018 at the Henry B. Gonzalez Convention Center in San Antonio, TX.
Xhale Assurance announced today that it will showcase its Nasal Alar SpO2 Sensor at the AANA2017 Nurse Anesthesia Annual Congress, hosted by the American Association of Nurse Anesthetists. The Congress will be taking place September 9 – 12, 2017 at the Washington State Convention Center, halls 4A and 4B in Seattle, WA. Xhale Assurance will […]
Xhale submits Biomarker Qualification package to FDA for Medication Adherence Monitoring Tool. Gainesville, FL, September 21, 2015 Xhale, Inc. announced today that it has submitted to the Food and Drug Administration (FDA) the first Biomarker Qualification package for a Drug Development Tool for medication adherence monitoring. The submittal to FDA marks an important step […]
Xhale Assurance announced today that it has received CE Mark approval for its Nasal Alar SpO2 Sensor which allows for nasal ala oximetry utilizing a highly dependable central site. GAINESVILLE, FL August 21, 2015 – Xhale Assurance, Inc. Xhale Assurance, Inc. today announced it has received CE Mark approval of its Nasal Alar […]
Xhale Assurance, Inc., developer of the patented Assurance® Nasal AlarSpO2TM Sensor, today announced FDA clearance and the global launch of its second-generation pulse oximetry sensor. The new Assurance® Nasal AlarSpO2TM Sensor is now compatible with the majority of pulse oximetry monitors in use in a wide variety of health care settings. “The Assurance® Nasal AlarSpO2TM […]
